Balanced news tone
News Sentiment
PODD sentiment intelligence
Insulet Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
46
Balanced news tone
64 relevant articles
News tone and price action are not far from neutral.
72/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, +7.7% over four weeks, trend inactive, and below fair value.
Insulet Corp (PODD) Stock Up 3.2% and Still Undervalued -- GF Sc
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
72/100 classification
One-week reaction
-1.9%
Price digesting
Trend fit
Trend inactive
7.7% over four weeks
Fair value
-31.0%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
13
Neutral
33
Negative
18
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
MT Newswires
Direct company coverage
Stifel Adjusts Price Target on Insulet to $225 From $250
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jul 2026 11:28
- Source
- MT Newswires
ad-hoc-news.de
Direct company coverage
Insulet stock reflects steady diabetes tech demand as investors watch U.S. growth
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 10 Jul 2026 07:15
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Insulet (PODD) Stock Still Trades At A Premium As Shares Fell 47%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:12
- Source
- Market source
Market source
Direct company coverage
Insulet (PODD) Launches Omnipod 5 In Spain, Is The Stock Cheap?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 06:14
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Insulet focuses on diabetes technology growth. Business model supports recurring revenue
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Jul 2026 10:27
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Is Insulet Corporation (PODD) Stock Still a Diabetes Device Growth Opportunity After Analyst Target Cut?
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 07:00
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Omnipod Dash from Insulet - lightweight patch pump for everyday diabetes care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- ad-hoc-news.de
Stock Titan
Direct company coverage
Insulet will report Q2 results Aug. 5, with a call at 8 a.m.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Can Insulet’s (PODD) Closed-Loop Type 2 Data Reframe Its Long-Term Diabetes Tech Narrative?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Bank of America Securities Maintains Buy Rating on Insulet (PODD) Stock
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 21 Jun 2026 07:00
- Source
- Market source
StockStory
Industry context
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
Market source
Direct company coverage
Is Insulet Corporation (PODD) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Independent Chair of Insulet Picks Up 66% More Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
How Insulet’s next-gen Omnipod is designed to reduce the work of diabetes care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Insulet Recall Puts Omnipod Reliability And Valuation In Investor Focus
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 28 May 2026 07:00
- Source
- simplywall.st
Business Wire
Direct company coverage
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Business Wire
ad-hoc-news.de
Direct company coverage
Insulet stock (US45784P1012): investors digest 2026 AGM decisions and bylaw changes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- ad-hoc-news.de
Market source
Industry context
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Why Insulet (PODD) Stock Is Trading Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Some May Be Optimistic About Insulet's (NASDAQ:PODD) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Insulet (PODD) is an Incredible Growth Stock: 3 Reasons Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Is It Time To Reassess Insulet (PODD) After A 31.9% One-Year Share Price Fall
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
A Look At Insulet (PODD) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
TIKR.com
Direct company coverage
Insulet Stock Drops 7% After Omnipod 5 Recall
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 16 Mar 2026 07:00
- Source
- TIKR.com
StockStory
Industry context
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Market source
Industry context
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source